Incomplete Estrogen Suppression With Gonadotropin- Releasing Hormone Agonists May Reduce Clinical Efficacy in Premenopausal Women With Early Breast Cancer

被引：25
作者：
Dowsett, Mitch [1 ]
Lonning, Per E. [2 ,3 ]
Davidson, Nancy E. [4 ,5 ]
机构：
[1] Royal Marsden Hosp, London SW3 6JJ, England
[2] Univ Bergen, Bergen, Norway
[3] Haukeland Hosp, N-5021 Bergen, Norway
[4] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA
[5] UPMC CancerCtr, Pittsburgh, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 14期
关键词：
OVARIAN-FUNCTION SUPPRESSION; AROMATASE INHIBITORS; ENDOCRINE THERAPY; PHASE-III; TAMOXIFEN; COMBINATION; EXEMESTANE; TRIAL;
D O I：
10.1200/JCO.2015.62.3728
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1580 / U64
页数：6
相关论文
共 27 条
[1]  
Abe O, 2005, LANCET, V366, P2087, DOI 10.1016/s0140-6736(05)66544-0
[2]  
[Anonymous], 1996, Lancet, V348, P1189
[3]   Twelve-Month Estrogen Levels in Premenopausal Women With Hormone Receptor-Positive Breast Cancer Receiving Adjuvant Triptorelin Plus Exemestane or Tamoxifen in the Suppression of Ovarian Function Trial (SOFT): The SOFT-EST Substudy [J].
Bellet, Meritxell ;
Gray, Kathryn P. ;
Francis, Prudence A. ;
Lang, Istvan ;
Ciruelos, Eva ;
Lluch, Ana ;
Angel Climent, Miguel ;
Catalan, Gustavo ;
Avella, Antoni ;
Bohn, Uriel ;
Gonzalez-Martin, Antonio ;
Ferrer, Roser ;
Catalan, Roberto ;
Azaro, Analia ;
Rajasekaran, Agnita ;
Morales, Josefa ;
Vazquez, Josep ;
Fleming, Gini F. ;
Price, Karen N. ;
Regan, Meredith M. .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (14) :1584-U89
[4]   Review: Aromatase inhibitors for ovulation induction [J].
Casper, RF ;
Mitwally, MFM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (03) :760-771
[5]  
Cuzick J, 2007, LANCET, V369, P1711
[6]   AROMATIZATION INHIBITION ALONE OR IN COMBINATION WITH GNRH AGONISTS FOR THE TREATMENT OF PREMENOPAUSAL BREAST-CANCER PATIENTS [J].
DOWSETT, M ;
STEIN, RC ;
COOMBES, RC .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1992, 43 (1-3) :155-159
[7]   Vorozole results in greater oestrogen suppression than formestane in postmenopausal women and when added to goserelin in premenopausal women with advanced breast cancer [J].
Dowsett, M ;
Doody, D ;
Miall, S ;
Howes, A ;
English, J ;
Coombes, RC .
BREAST CANCER RESEARCH AND TREATMENT, 1999, 56 (01) :25-34
[8]   The biology of steroid hormones and endocrine treatment of breast cancer [J].
Dowsett, M ;
Folkerd, E ;
Doody, D ;
Haynes, B .
BREAST, 2005, 14 (06) :452-457
[9]  
DOWSETT M, 1992, CLIN THER, V14, P97
[10]   Adjuvant Ovarian Suppression in Premenopausal Breast Cancer [J].
Francis, Prudence A. ;
Regan, Meredith M. ;
Fleming, Gini F. ;
Lang, Istvan ;
Ciruelos, Eva ;
Bellet, Meritxell ;
Bonnefoi, Herve R. ;
Climent, Miguel A. ;
Da Prada, Gian Antonio ;
Burstein, Harold J. ;
Martino, Silvana ;
Davidson, Nancy E. ;
Geyer, Charles E., Jr. ;
Walley, Barbara A. ;
Coleman, Robert ;
Kerbrat, Pierre ;
Buchholz, Stefan ;
Ingle, James N. ;
Winer, Eric P. ;
Rabaglio-Poretti, Manuela ;
Maibach, Rudolf ;
Ruepp, Barbara ;
Giobbie-Hurder, Anita ;
Price, Karen N. ;
Colleoni, Marco ;
Viale, Giuseppe ;
Coates, Alan S. ;
Goldhirsch, Aron ;
Gelber, Richard D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (05) :436-446
123